Table 6.

The Number of Patients Who Showed Negative Results in CCT or SIT Despite Baseline PAC ≥ 30.85 ng/dL

Baseline PRA (ng/ml/h)Captopril Challenge Test (n = 32)Saline Infusion Test (n = 2)
PRA ≤ 0.330
0.3 < PRA ≤ 0.410
0.4 < PRA ≤ 0.530
0.5 < PRA ≤ 0.600
0.6 < PRA ≤ 0.772
0.7 < PRA ≤ 0.810
0.8 < PRA ≤ 1.070
PRA > 1.0100
Baseline PRA (ng/ml/h)Captopril Challenge Test (n = 32)Saline Infusion Test (n = 2)
PRA ≤ 0.330
0.3 < PRA ≤ 0.410
0.4 < PRA ≤ 0.530
0.5 < PRA ≤ 0.600
0.6 < PRA ≤ 0.772
0.7 < PRA ≤ 0.810
0.8 < PRA ≤ 1.070
PRA > 1.0100

Abbreviations: CCT, captopril challenge test; PAC, plasma aldosterone concentration; PRA, plasma renin activity; SIT, saline infusion test.

Table 6.

The Number of Patients Who Showed Negative Results in CCT or SIT Despite Baseline PAC ≥ 30.85 ng/dL

Baseline PRA (ng/ml/h)Captopril Challenge Test (n = 32)Saline Infusion Test (n = 2)
PRA ≤ 0.330
0.3 < PRA ≤ 0.410
0.4 < PRA ≤ 0.530
0.5 < PRA ≤ 0.600
0.6 < PRA ≤ 0.772
0.7 < PRA ≤ 0.810
0.8 < PRA ≤ 1.070
PRA > 1.0100
Baseline PRA (ng/ml/h)Captopril Challenge Test (n = 32)Saline Infusion Test (n = 2)
PRA ≤ 0.330
0.3 < PRA ≤ 0.410
0.4 < PRA ≤ 0.530
0.5 < PRA ≤ 0.600
0.6 < PRA ≤ 0.772
0.7 < PRA ≤ 0.810
0.8 < PRA ≤ 1.070
PRA > 1.0100

Abbreviations: CCT, captopril challenge test; PAC, plasma aldosterone concentration; PRA, plasma renin activity; SIT, saline infusion test.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close